X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4210) 4210
Publication (506) 506
Book Review (50) 50
Book Chapter (23) 23
Book / eBook (10) 10
Conference Proceeding (9) 9
Dissertation (8) 8
Magazine Article (3) 3
Newspaper Article (3) 3
Newsletter (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2831) 2831
humans (2543) 2543
animals (2264) 2264
male (1327) 1327
mice (1219) 1219
receptor for advanced glycation end products (1206) 1206
inflammation (1075) 1075
receptor (935) 935
glycation end-products (934) 934
female (875) 875
proteins (846) 846
expression (766) 766
rage (765) 765
diabetes (753) 753
oxidative stress (749) 749
receptors, immunologic - genetics (696) 696
research (693) 693
signal transduction (675) 675
receptors, immunologic - metabolism (662) 662
medicine (633) 633
research article (631) 631
rats (618) 618
cell biology (615) 615
gene expression (611) 611
biochemistry & molecular biology (577) 577
activation (568) 568
rodents (547) 547
cells, cultured (544) 544
middle aged (534) 534
multidisciplinary sciences (531) 531
physiological aspects (484) 484
glycation end products, advanced - metabolism (483) 483
immunology (483) 483
science (471) 471
genetic aspects (464) 464
health aspects (453) 453
mice, inbred c57bl (453) 453
risk factors (449) 449
endocrinology & metabolism (447) 447
apoptosis (444) 444
atherosclerosis (426) 426
medicine, research & experimental (413) 413
diabetes mellitus (401) 401
aged (398) 398
glycosylation (392) 392
cytokines (391) 391
disease models, animal (360) 360
mice, knockout (360) 360
disease (357) 357
adult (351) 351
kinases (349) 349
article (345) 345
ligands (338) 338
biology (333) 333
review (327) 327
pathogenesis (324) 324
advanced glycosylation end products (321) 321
receptor for advanced glycation end products - metabolism (316) 316
analysis (315) 315
development and progression (313) 313
cells (304) 304
receptor for advanced glycation end products - genetics (302) 302
physiology (298) 298
cell line (290) 290
studies (289) 289
care and treatment (286) 286
neurosciences (276) 276
cancer (275) 275
hmgb1 protein - metabolism (269) 269
toll-like receptors (269) 269
glucose (268) 268
oncology (263) 263
nf-kappa b - metabolism (261) 261
age (259) 259
receptors (257) 257
biochemistry (254) 254
rna, messenger - metabolism (249) 249
complications (247) 247
nf-kappa-b (243) 243
phosphorylation (236) 236
advanced glycation end products (234) 234
reverse transcriptase polymerase chain reaction (229) 229
hmgb1 (228) 228
signal transduction - drug effects (228) 228
blotting, western (224) 224
gene-expression (222) 222
metabolism (221) 221
immunohistochemistry (219) 219
pharmacology & pharmacy (219) 219
endothelial-cells (212) 212
gene expression regulation (212) 212
rna, messenger - genetics (209) 209
pathology (208) 208
rats, sprague-dawley (208) 208
up-regulation (208) 208
macrophages (206) 206
soluble receptor (206) 206
protein (203) 203
type 2 diabetes (200) 200
article subject (198) 198
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2015, Volume 90, pp. 84 - 93
Abstract Both type 1 and type 2 diabetes are associated with cardiac fibrosis that may reduce myocardial compliance, contribute to the pathogenesis of heart... 
Cardiovascular | Heart failure | Obesity | Diabetes | Fibroblast | Fibrosis | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | REGULATES FIBROBLAST PHENOTYPE | EXTRACELLULAR-MATRIX PRODUCTION | HEART-FAILURE | DIASTOLIC DYSFUNCTION | CELL BIOLOGY | GROWTH-FACTOR-BETA | COLLAGEN TYPE-I | INTENSIVE GLYCEMIC CONTROL | RENIN-ANGIOTENSIN SYSTEM | GLYCATION END-PRODUCTS | Diabetes Mellitus - pathology | Diabetic Cardiomyopathies - metabolism | Diabetic Cardiomyopathies - drug therapy | Diabetes Mellitus - genetics | Humans | Endomyocardial Fibrosis - drug therapy | Endomyocardial Fibrosis - genetics | Endomyocardial Fibrosis - pathology | Receptor for Advanced Glycation End Products - genetics | Extracellular Matrix Proteins - metabolism | Glycation End Products, Advanced - genetics | Hypoglycemic Agents - therapeutic use | Macrophages - pathology | Signal Transduction | Endothelial Cells - metabolism | Extracellular Matrix Proteins - genetics | Receptor for Advanced Glycation End Products - metabolism | Diabetes Mellitus - drug therapy | Gene Expression Regulation | Diabetes Mellitus - metabolism | Smad Proteins - genetics | Diabetic Cardiomyopathies - genetics | Myocytes, Cardiac - pathology | Macrophages - metabolism | Animals | Myocytes, Cardiac - drug effects | Transforming Growth Factor beta - genetics | Glycation End Products, Advanced - metabolism | Endomyocardial Fibrosis - metabolism | Myocytes, Cardiac - metabolism | Diabetic Cardiomyopathies - pathology | Macrophages - drug effects | Renin-Angiotensin System - drug effects | Endothelial Cells - pathology | Smad Proteins - metabolism | Transforming Growth Factor beta - metabolism | Endothelial Cells - drug effects | Type 2 diabetes | Bone morphogenetic proteins | Health aspects | Angiotensin
Journal Article
Molecular Medicine, ISSN 1076-1551, 10/2015, Volume 21, Issue S1, pp. S32 - S40
A nonenzymatic reaction between reducing sugars and amino groups of proteins, lipids and nucleic acids contributes to the aging of macromolecules and... 
MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | POSITIVE ASSOCIATION | CELL BIOLOGY | FACTOR PEDF | ASYMMETRIC DIMETHYLARGININE GENERATION | SOLUBLE FORM | SERUM-LEVELS | NEUTRALIZING RAGE-ANTIBODY | ENDOTHELIAL GROWTH-FACTOR | Dipeptidyl Peptidase 4 - metabolism | Alzheimer Disease - complications | Oxidative Stress | Cardiovascular Diseases - drug therapy | Diabetes Mellitus, Type 2 - genetics | Humans | Glycation End Products, Advanced - antagonists & inhibitors | Osteoporosis - drug therapy | Diabetes Mellitus, Type 1 - complications | Cardiovascular Diseases - pathology | Cardiovascular Diseases - genetics | Alzheimer Disease - pathology | Neoplasms - complications | Cardiovascular Diseases - complications | Diabetic Angiopathies - pathology | Neoplasms - genetics | Diabetic Angiopathies - complications | Osteoporosis - genetics | Receptor for Advanced Glycation End Products - genetics | Diabetic Angiopathies - genetics | Diabetes Mellitus, Type 2 - complications | Gene Expression | Receptor for Advanced Glycation End Products - metabolism | Diabetes Mellitus, Type 1 - pathology | Alzheimer Disease - drug therapy | Diabetes Mellitus, Type 1 - genetics | Aptamers, Nucleotide - therapeutic use | Dipeptidyl Peptidase 4 - genetics | Diabetic Angiopathies - drug therapy | Diabetes Mellitus, Type 1 - drug therapy | Neoplasms - drug therapy | Osteoporosis - pathology | Glycation End Products, Advanced - metabolism | Osteoporosis - complications | Diabetes Mellitus, Type 2 - pathology | Alzheimer Disease - genetics | Diabetes Mellitus, Type 2 - drug therapy | Neoplasms - pathology | Adenosine Deaminase Inhibitors - therapeutic use
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 136, Issue 3, pp. 747 - 756.e4
Background Single nucleotide polymorphisms in the human gene for the receptor for advanced glycation end-products (RAGE) are associated with an increased... 
Allergy and Immunology | group 2 innate lymphoid cells | IL-33 | Asthma | receptor for advanced glycation end-products | LEUKOCYTE RECRUITMENT | ALLERGIC LUNG INFLAMMATION | RAGE | IMMUNOLOGY | RESPONSES | EPITHELIAL-CELLS | ALLERGY | IN-VIVO | TYPE-2 IMMUNITY | MICE | EXPRESSION | ALTERNARIA | Bone Marrow - immunology | Cell Proliferation | Spleen - immunology | Interleukin-13 - immunology | Interleukin-5 - genetics | Interleukin-33 - immunology | Gastrointestinal Tract - pathology | Allergens - administration & dosage | Antigens, Dermatophagoides - immunology | Gastrointestinal Tract - immunology | Interleukin-13 - genetics | Peritoneum - pathology | Receptor for Advanced Glycation End Products - immunology | Lymphocytes - immunology | Allergens - immunology | Antigens, Dermatophagoides - administration & dosage | Asthma - immunology | Peritoneum - immunology | Receptor for Advanced Glycation End Products - genetics | Spleen - pathology | Lung - pathology | Pyroglyphidae - chemistry | Signal Transduction | Gene Expression Regulation | Immunity, Innate | Organ Specificity | Transplantation Chimera | Asthma - chemically induced | Asthma - genetics | Interleukin-5 - immunology | Interleukin-33 - genetics | Lymphocytes - pathology | Animals | Bone Marrow - pathology | Mice | Alternaria - chemistry | Asthma - pathology | Lung - immunology | Chromosomes | Single nucleotide polymorphisms | Studies | Cytokines | Pathogenesis | Lymphocytes | Rodents | Inflammation | Laboratory animals | Allergies | Cell adhesion & migration
Journal Article
Journal Article
Journal Article
British Journal of Nutrition, ISSN 0007-1145, 12/2015, Volume 115, Issue 4, pp. 629 - 636
Dietary advanced glycation end products (AGE) formed during heating of food have gained interest as potential nutritional toxins with adverse effects on... 
Advanced glycation end products | Gene for advanced glycation end product receptor 1 | Insulin sensitivity | Gene for receptor for advanced glycation end products | Rats | Gene expression | Body composition | METABOLIC TRANSIT | LIFE-SPAN | ACTIVATION | OXIDANT STRESS | FOODS | GLYCOTOXINS | ENDPRODUCTS AGES | NUTRITION & DIETETICS | RESTRICTED INTAKE | INSULIN-RESISTANCE | MICE | Tumor Necrosis Factor-alpha - metabolism | Up-Regulation | Glycation End Products, Advanced - administration & dosage | Biomarkers - urine | Molecular Weight | Lysine - urine | Diet - adverse effects | Tumor Necrosis Factor-alpha - blood | Tumor Necrosis Factor-alpha - genetics | Milk Proteins - adverse effects | Male | Hexosyltransferases - metabolism | Milk Proteins - administration & dosage | Milk Proteins - chemistry | Proteolysis | Glycation End Products, Advanced - adverse effects | Receptor for Advanced Glycation End Products - genetics | Hexosyltransferases - blood | Receptor for Advanced Glycation End Products - blood | Lysine - analogs & derivatives | Hot Temperature - adverse effects | Receptor for Advanced Glycation End Products - metabolism | Hexosyltransferases - genetics | Biomarkers - blood | Random Allocation | Receptor for Advanced Glycation End Products - agonists | Energy Intake | Rats, Sprague-Dawley | Glycation End Products, Advanced - urine | Renal Elimination | Animals | Glycation End Products, Advanced - chemistry | Toxicity Tests, Subacute | Hexosyltransferases - chemistry | Imidazolines - urine | Imidazoles - urine
Journal Article
PLoS ONE, ISSN 1932-6203, 2016, Volume 11, Issue 1, p. e0141000
Journal Article